Luca Mologni

Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification

Philipp le Coutre, E. ̃Tassi, Marileila Varella‐Garcia et al. · Blood · 2000 · 487 citations

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Rocco Piazza, Simona Valletta, Nils Winkelmann et al. · Nature Genetics · 2012 · 422 citations · Full text

Hematological Malignancy, Hematology, Medicine +4

In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

Philipp le Coutre, Luca Mologni, Loredana Cleris et al. · JNCI Journal of the National Cancer Institute · 1999 · 377 citations · Full text

Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

Carlo Gambacorti‐Passerini, Philipp le Coutre, Luca Mologni et al. · Blood Cells Molecules and Diseases · 1997 · 317 citations

Hematological Malignancy, Cancer Research, Mixed-phenotype Acute Leukemia +9

Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

Elena Ardini, Maria Menichincheri, Patrizia Banfi et al. · Molecular Cancer Therapeutics · 2016 · 308 citations · Full text